Abstract
AbstractAlleviating the multiple problems of children with autism spectrum disorder (ASD) and its comorbid conditions presents major challenges for the affected children, parents, and therapists. Because of a complex psychopathology, structured therapy and parent training are not always sufficient, especially for those patients with intellectual disability (ID) and multiple comorbidities. Moreover, structured therapy is not available for a large number of patients, and pharmacological support is often needed, especially in those children with additional attention deficit/hyperactivity and oppositional defiant, conduct, and sleep disorders.
Funder
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Psychology
Reference326 articles.
1. Aadil M, Cosme RM, Chernaik J. Mindfulness-based cognitive behavioral therapy as an adjunct treatment of Attention Deficit Hyperactivity disorder in young adults: A literature review. Cureus. 2017;9(5):e1269. https://doi.org/10.7759/cureus.1269.
2. Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019;19(328):1–10. https://doi.org/10.1186/s12888-019-2259-4.
3. Allen A, Kurlan R, Gilbert D, Dunn D, Dallee FR, Spencer T. Atomoxetine treatment in children with ADHD and comorbid tic disorders. In: 16th World Congress of IACAPAP. Darmstadt: Steinkopff; 2004. pp. 311–31.
4. Aman MG, Buican B, Arnold LE. Methylphenidate treatmentin children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol. 2003;13(1):29–40.
5. Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, et al. A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014;35(6):1412–24. https://doi.org/10.1016/j.ridd.2014.03.006.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献